General surgery

BON SECOURS MERCY HEALTH AND COMPASS SURGICAL PARTNERS TO OPEN STATE-OF-THE-ART OUTPATIENT SURGERY CENTER IN SPRINGFIELD, OHIO

Retrieved on: 
Wednesday, February 7, 2024
Partnership, BSN, Certification, Physician, Gastroenterology, Hospital, Patient, OB/GYN, General surgery, Podiatry, Bon, Abdominal ultrasonography, Elective surgery, ASC, Quality of life, Accreditation, Neurosurgery, Health, D.O, RN, Mercy Health, Operating

SPRINGFIELD, Ohio and RALEIGH, N.C., Feb. 7, 2024 /PRNewswire/ -- Springfield Regional Outpatient Surgery Center, a joint venture between Bon Secours Mercy Health, Compass Surgical Partners (Compass), and local physicians, today announced the opening of its new 12,000-square-foot ambulatory surgery center (ASC) in Springfield, Ohio.

Key Points: 
  • SPRINGFIELD, Ohio and RALEIGH, N.C., Feb. 7, 2024 /PRNewswire/ -- Springfield Regional Outpatient Surgery Center, a joint venture between Bon Secours Mercy Health, Compass Surgical Partners (Compass), and local physicians, today announced the opening of its new 12,000-square-foot ambulatory surgery center (ASC) in Springfield, Ohio.
  • Located at 2610 North Limestone Street, Springfield Regional Outpatient Surgery Center will offer procedures across a host of specialties, including neurosurgery, orthopedics, podiatry, plastic surgery, interventional pain management, OB/GYN, gastroenterology and general surgery.
  • "Compass is thrilled to partner with Mercy Health to establish and operate the Springfield Regional Outpatient Surgery Center, which will provide top-notch care in a comfortable outpatient setting," added Scott Bergman, Market President at Compass Surgical Partners.
  • Springfield Regional Outpatient Surgery Center is seeking accreditation from the Accreditation Association for Ambulatory Health Care and certification from Medicare.

SS Innovations Demonstrates Groundbreaking Telesurgery Platform at Company’s First Multi-Specialty Robotic Surgical Conference

Retrieved on: 
Thursday, February 1, 2024
Conference, General surgery, OTC, SSI, Artificial intelligence, Gynaecology, Urology, Medical device

FORT LAUDERDALE, Fla., Feb. 01, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, conducted a groundbreaking live telesurgery demonstration at the inaugural SS Innovations Multi-Specialty Robotic Surgical Conference (SMRSC) that was held in Gurugram, Haryana, India on January 19 and 20, 2024. SS Innovations Founder, Chairman and Chief Executive Officer, Dr. Sudhir Srivastava, through SS Innovations’ Telesurgery Platform, performed a remote coronary artery suturing demonstration on an animal model during the conference’s first day to acclaim from the audience of more than 350 participants.

Key Points: 
  • FORT LAUDERDALE, Fla., Feb. 01, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, conducted a groundbreaking live telesurgery demonstration at the inaugural SS Innovations Multi-Specialty Robotic Surgical Conference (SMRSC) that was held in Gurugram, Haryana, India on January 19 and 20, 2024.
  • SS Innovations Founder, Chairman and Chief Executive Officer, Dr. Sudhir Srivastava, through SS Innovations’ Telesurgery Platform, performed a remote coronary artery suturing demonstration on an animal model during the conference’s first day to acclaim from the audience of more than 350 participants.
  • Panel discussions and scientific sessions featured distinguished international faculty, sharing insights on the future of robotic surgery across the world.
  • The SSi Mantra™ Surgical Robotic System is the first surgical system to be made in India, and one of the only systems in the world to be cost-effective with broad-spectrum surgical applications including cardiac surgery.

AbSolutions Med, Inc. Receives FDA Breakthrough Device Designation for its REBUILD™ Bioabsorbable Abdominal Wall Closure Device

Retrieved on: 
Thursday, January 25, 2024
Patient, Incisional hernia, General surgery, Abdominal wall, Medicine, Risk, Quality of life, Disease, Food, FDA, Three-body problem, Laparotomy

MOUNTAIN VIEW, Calif., Jan. 24, 2024 (GLOBE NEWSWIRE) -- AbSolutions Med, Inc., a privately held medical device company, announced today that the Food and Drug Administration (FDA) has granted Breakthrough Device Designation for its REBUILD Bioabsorbable (“REBUILD”) abdominal wall closure device.

Key Points: 
  • MOUNTAIN VIEW, Calif., Jan. 24, 2024 (GLOBE NEWSWIRE) -- AbSolutions Med, Inc., a privately held medical device company, announced today that the Food and Drug Administration (FDA) has granted Breakthrough Device Designation for its REBUILD Bioabsorbable (“REBUILD”) abdominal wall closure device.
  • REBUILD met the criteria set by the FDA for Breakthrough Devices, potentially providing a novel treatment of an often irreversibly debilitating condition: incisional hernia.
  • Since the first documented laparotomy in 1809, general surgery has been challenged by its limitations in reliably managing a basic but fundamental aspect of abdominal surgery – closure of the abdominal wall.
  • The impact of a failed abdominal closure can be devastating, with lifelong debilitation, morbidity, and re-operation occurring in a large percentage of patients.

SS Innovations Launches Groundbreaking Inaugural Multi-Specialty Robotic Surgical Conference

Retrieved on: 
Monday, January 22, 2024
Aster, Artificial intelligence, General surgery, Urology, Apollo Hospitals, The Honourable, RGCI, Hysterectomy, Cholecystectomy, Medanta, OTC, Conference, Hospital, Cystectomy, Mantra, Incisional hernia, Medical device

FORT LAUDERDALE, Fla., Jan. 22, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, is proud to have presented the inaugural SS Innovations Multi-Specialty Robotic Surgical Conference (SMRSC), that was held at The Leela Ambience Hotel in Gurugram, Haryana, India on January 19 and 20, 2024. The meeting was highly attended with more than 600 visitors over the course of two days.

Key Points: 
  • 13 Live, broadcasted surgeries were performed by distinguished multi-specialty surgeons, using the SSi Mantra Surgical Robotic System
    Distinguished guests included the Honorable Governor of Haryana, Mr. Bandaru Dattatreya
    FORT LAUDERDALE, Fla., Jan. 22, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, is proud to have presented the inaugural SS Innovations Multi-Specialty Robotic Surgical Conference (SMRSC), that was held at The Leela Ambience Hotel in Gurugram, Haryana, India on January 19 and 20, 2024.
  • SMRSC 2024 was a transformative event that brought together global medical experts, technological innovators, and visionaries to explore the future of robotic surgery, with a specific focus on SS Innovations’ flagship surgical robotic system, the SSi Mantra.
  • SMRSC 2024 was a productive and educational event that showcased the SSi Mantra, SS Innovations’ technologically advanced, affordable, and accessible surgical robotic system, and SSi Maya, our groundbreaking virtual and mixed reality development division that we anticipate will allow us to launch robotic programs using tele-proctoring and tele-surgery.
  • The conference endeavors to set the stage for the future of healthcare with the SSi Mantra Surgical Robotic System.

The Inner Circle Acknowledges, Hank C. Hill as a Pinnacle Life Member

Retrieved on: 
Monday, January 29, 2024
Surgical oncology, Philosophy, Neoplasm, Patient, Annals of Surgical Oncology, Research, Endocrine system, Sarcoma, Radiation, ABS, General surgery, Mentorship, Dance, Health, Multimedia, Knowledge, Music, Inner circle, Surgeon, National Research Service Award, Society, University, MD Anderson Cancer Center, Cancer, Skin, Gastrointestinal tract, Harlem Hospital Center, Esophagus, NIH, Liver, Stomach, Rectum, T-32, Morehouse School of Medicine, Breast, Tennis, Education, Publication, Pancreas, Endoscopy, Nursing

BROOKSVILLE, Fla., Jan. 29, 2024 /PRNewswire/ -- Prominently featured in The Inner Circle, Hank C. Hill is acknowledged as a Pinnacle Life Member for his contributions to the field of Surgical Oncology.

Key Points: 
  • BROOKSVILLE, Fla., Jan. 29, 2024 /PRNewswire/ -- Prominently featured in The Inner Circle, Hank C. Hill is acknowledged as a Pinnacle Life Member for his contributions to the field of Surgical Oncology.
  • Dr. Hill pursued higher education at the Brooklyn Campus of Long Island University where he earned his Bachelor of Science degree in Biology/Pre-Med.
  • Anderson Cancer Center in Houston, where he earned a surgical oncology research fellowship certificate in tumor biology.
  • Aside from his professional pursuits, Dr. Hill enjoys traveling, dancing (soca, reggae, reggaeton, R&B), and listening to music.

Johnson & Johnson Reports Q4 and Full-Year 2023 Results

Retrieved on: 
Tuesday, January 23, 2024
Biotechnology, Health, Pharmaceutical, Clinical Trials, Oncology, Growth, Contact, Ustekinumab, Esketamine, General surgery, Infliximab, Abiraterone acetate, Press release, Acquisition, COVID-19, Medtech, Johnson & Johnson, Abiomed, Daratumumab, Security (finance), News, Pharmaceutical industry

Adjusted operational sales* reflected below excludes the net impact of acquisitions and divestitures and translational currency.

Key Points: 
  • Adjusted operational sales* reflected below excludes the net impact of acquisitions and divestitures and translational currency.
  • Innovative Medicine worldwide operational sales, excluding the COVID-19 Vaccine, grew 7.2%*.
  • Notable New Announcements in the Quarter:
    The information contained in this section should be read together with Johnson & Johnson’s other disclosures filed with the Securities and Exchange Commission, including its Current Reports on Form 8-K, Quarterly Reports on Form 10-Q and Annual Reports on Form 10-K.
  • Copies of these filings are available online at www.sec.gov , www.jnj.com or on request from Johnson & Johnson.

Olympus Announces Full Market Availability of Redesigned Energy Platform

Retrieved on: 
Wednesday, January 24, 2024
LCD, HF, Olympus Corporation, Hospital, General surgery, Elective surgery, Urology, Injury, Turís, Society, Operating, Gynaecology, STS, Plasma, Bipolar, Movement, System

CENTER VALLEY, Pa., Jan. 24, 2024 /PRNewswire/ -- Olympus Corporation, a global medical technology company committed to making people's lives healthier, safer and more fulfilling, announced today full market availability of its new ESG-410™ Surgical Energy Platform for conventional monopolar and bipolar, advanced energy applications now including ultrasonic dissection and hybrid energy.

Key Points: 
  • The ESG-410™ Surgical Energy Platform, the Heart of Every Procedure, Positions Olympus as a Comprehensive Energy Solution Provider
    CENTER VALLEY, Pa., Jan. 24, 2024 /PRNewswire/ -- Olympus Corporation, a global medical technology company committed to making people's lives healthier, safer and more fulfilling, announced today full market availability of its new ESG-410™ Surgical Energy Platform for conventional monopolar and bipolar, advanced energy applications now including ultrasonic dissection and hybrid energy.
  • The ESG-410 Surgical Energy Platform delivers a comprehensive energy solution with applications across numerous specialties such as general surgery, thoracic surgery, urology, and gynecology.
  • The ESG-410 generator is part of the Olympus energy portfolio that offers hospitals an all-in-one energy solution for any operating room and powers the full range of Olympus Energy systems: monopolar, bipolar (HiQ™, HICURA™, PK™ and Everest™ devices), ultrasonic (SONICBEAT™ devices), hybrid energy (THUNDERBEAT™ devices) and advanced bipolar (POWERSEAL™ devices).
  • For more information, visit the Olympus booth #1831 at STS or for more information about the Olympus energy portfolio visit the POWERSEAL , THUNDERBEAT and ESG-410 product pages.

Los Angeles Vasectomy and Vasectomy Reversal Specialist, Dr. Justin Houman, is Appointed Assistant Professor at Cedars-Sinai Medical Center

Retrieved on: 
Tuesday, January 23, 2024
Student, LOS, Patient, American Urological Association, Infertility, General surgery, Peyronie's disease, Health, Urology, Multimedia, Knowledge, Male, Reproductive medicine, Men's Health, University, Quality of life, Vasectomy, Incontinence, Suite, Erectile dysfunction, Cedars-Sinai Medical Center, International Society, Education, Testosterone, Physician, Birth control

LOS ANGELES, Jan. 23, 2024 /PRNewswire-PRWeb/ -- As an esteemed assistant professor in urology at Cedars-Sinai Medical Center, Dr. Justin Houman will continue enhancing the quality of life for men by improving their sexual, reproductive and hormonal health. Dr. Houman provides his patients with the latest and most effective treatments available, with extensive expertise in vasectomy, vasectomy reversal, infertility, testosterone, Peyronie's disease, erectile dysfunction and urology. Also, as a top minimally invasive microscopic surgeon, Dr. Houman delivers skill and expertise in microsurgical varicocelectomies, vasectomy reversals, sperm retrievals, penile implants and male incontinence. His vast knowledge and experience in urology have earned him recognition as a leading authority in men's health. Dr. Houman's appointment at Cedars-Sinai Medical Center is a testament to his exceptional skills, dedication and unwavering commitment to patient care. As an assistant professor, Dr. Houman will continue to contribute to the advancement of urological research and education for his patients and students.

Key Points: 
  • Board-certified and fellowship-trained urologist, Dr. Justin Houman, is a top men's health specialist and leading urological surgeon in the Los Angeles area.
  • LOS ANGELES, Jan. 23, 2024 /PRNewswire-PRWeb/ -- As an esteemed assistant professor in urology at Cedars-Sinai Medical Center, Dr. Justin Houman will continue enhancing the quality of life for men by improving their sexual, reproductive and hormonal health.
  • Dr. Houman provides his patients with the latest and most effective treatments available, with extensive expertise in vasectomy, vasectomy reversal , infertility, testosterone, Peyronie's disease, erectile dysfunction and urology.
  • Dr. Houman's appointment at Cedars-Sinai Medical Center is a testament to his exceptional skills, dedication and unwavering commitment to patient care.

THE AMERICAN ACADEMY OF COSMETIC SURGERY (AACS) MARKS ITS 40th ANNIVERSARY WITH A COMPREHENSIVE SCIENTIFIC MEETING, PRE-MEETING WORKSHOP, AND DIVERSE OFFERINGS

Retrieved on: 
Tuesday, January 16, 2024
BBL, Dermatology, Research, Nutrition, Accreditation, Greatest, Surgeon, AACS, Lecture, ASM, General surgery, Hilton New Orleans Riverside, Practice management, Safety, Otorhinolaryngology, Plastic surgery, DMD, MPH, Breast, Education, Fountain of Youth, Physician, Immediate, American Journal, Elective surgery, Female, Male, Woman, Mortality, CME, Patient, Allied health professions, Rhinoplasty, Tropical medicine, Continuing medical education, Ophthalmology, Disease, DRS, American Academy, Public health, All, Patient safety, Dentistry

CHICAGO, Jan. 16, 2024 /PRNewswire/ -- The American Academy of Cosmetic Surgery (AACS), the world's largest multi-specialty home for physicians dedicated to cosmetic surgery and aesthetic medicine, will present its 40th Annual Scientific Meeting (ASM) on February 22-24, 2024, with an optional pre-meeting workshop on Ultrasound for Safe Brazilian Butt Lift Surgery and More, on Wednesday, February 21.

Key Points: 
  • In celebration of the AACS' 40th Annual Scientific Meeting, and the 40-year anniversary of the formation of the Academy and its official publication, The American Journal of Cosmetic Surgery, the meeting includes a comprehensive scientific program, as well as an array of advocacy, enrichment, networking and 40th anniversary celebratory activities.
  • Offering 41 educational sessions , the 2024 AACS ASM features foremost experts spanning diverse background specialties, such as dermatology, otolaryngology, general surgery, oral, and maxillofacial surgery, ophthalmology, and plastic and reconstructive surgery.
  • J. Kevin Duplechain, MD, FAACS, cosmetic surgeon and Immediate Past-President of the AACS and Cosmetic Surgery Foundation, will deliver the prestigious Webster Lecture on Friday, February 23.
  • Cosmetic surgery practitioners may register here for the 2024 AACS ASM.

IceCure Medical's ProSense® Featured at Indian Society of Vascular and Interventional Radiology Conference: Key Opinion Leaders Highlight Benefits of Cryoablation

Retrieved on: 
Tuesday, January 16, 2024
Gold, Neoplasm, Kidney, General surgery, Intervention, Society, Tissue, Breast cancer, Cryoablation, Freezing, Conference, Safety, Liver, Gold medal, Breast, Lung, Interventional radiology, Medical imaging

CAESAREA, Israel, Jan. 16, 2024 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure" or the "Company"), developer of the ProSense® System, a minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, today announced that it participated at the Indian Society of Vascular and Interventional Radiology (ISVIR) 24th Annual Conference in Jaipur, India that took place from January 11th-14th, 2024.

Key Points: 
  • IceCure, along with its in-country distributor, Novomed, exhibited and conducted hands-on ProSense® demonstrations and training.
  • In his presentation titled "Ablation for Bone and Soft Tissue Masses: How I Do It", ISVIR President Dr. Suyash Kulkarni, described the benefits of using a liquid nitrogen cryoablation system.
  • Dr. Kulkarni gave several specific examples of how his team performed cryoablation to successfully treat bone and soft tissue masses.
  • "At this year's ISVIR conference, more interventional radiologists evaluated the advantages of using cryoablation in their practices and hospitals."